ITMCTR2000003421已完成4 期
The randomized double-blind double-simulation and Non-inferior effect of positive control clinical trial study on the efficacy and safety of Yinhuang Qingfei Capsule in the treatment of acute exacerbation of chronic simple bronchitis
Center for Bioequivalence Studies and Clinical Research (CBSCR),International Center for Chemical and Biological Sciences(ICCBS),University of Karachi0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •1. Between the ages of 18-65, both male and female; with BMI 18.5-30kg/m2;
- •2. Satisfy the diagnostic criteria for acute exacerbation of Simple chronic bronchitis;
- •3. The main symptom score: expectoration quantification score>=2, cough + expectoration >=6;
- •4. Course of disease <=7 days;
- •5. The subject has signed the informed consent form.
排除标准
- •1. Through examination and verification, the chronic cough is caused by other diseases: pulmonary tuberculosis, pneumonia, pneumoconiosis, bronchial asthma, bronchiectasis, lung abscess, or caused by irritant gases, allergies, and ACE inhibitors;
- •2. With severe cardiopulmonary dysfunction, cardiopulmonary insufficiency;
- •3. Patients with severe primary cardiovascular, cerebrovascular, pulmonary, renal, endocrine and hematological diseases, and mental illness;
- •Patients with severe infections: WBC >=11.0 G/L, NEU% >=82%;
- •4. Subjects with a history if alchol or drug abuse,suspected or confirmed;
- •5. Body temperature exceed 38.5 degree C before signing consent form;
- •6. Subjects, who take other antiviral, antibacterial, cough relieving, expectorant and antiasthmatic drugs within 3 days prior to the visit(including beta 2 receptor agonists, anticholinergic agents, theophylline drugs, glucocorticoids, expectorant and Chinese Medicine.);
- •7. Allergic individuals and those who are known to be allergic to experimental drugs.(Have a clear history of penicillin and cephalosporins allergy.);
- •8. Pregnant women, lactating women or fertile women who are ready to conceive in 3 months;
- •9. Subject, who has participated in the past 3 months or is participating in another drug study;
- •10. The investigator believes that, there is other lesion or condition that reduces possibility of enrollment or makes the enrollment complex, such as changeable work environment, which easily leads to loss of follow-up;
- •11. Subjects who are not suitable for the clinical trial based on investigators judgment;
- •12. BMI>30kg/m2.
研究者
相似试验
尚未招募
4 期
The randomized double-blind double-simulation and parallel-controlled clinical trial study on the efficacy and safety of Weifuchuni Capsule in the treatment of chronic atrophic gastritisChronic atrophic gastritisITMCTR2000004204The First Affiliated Hospital of Zhejiang University of Chinese Medicine
已完成
不适用
Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)PER-053-05GLAXOSMITHKLINE PERU S.A.,
尚未招募
不适用
A randomized, double-blind, double-simulation, parallel control with positive drugs, multicenter clinical trial of Xuening tablet in treating iron deficiency anemia (deficiency of both qi and blood).Iron deficiency anemia (deficiency of both qi and blood)ITMCTR2200005569Dongzhimen Hospital Beijing University of Chinese Medicine
尚未招募
3 期
Study to Compare the Efficacy and Safety of Cilnidipine 10 mg Tablets versus Cilacar® Tablets 10 mg in Patients with Essential HypertensioCTRI/2021/03/031882MACLEODS PHARMACEUTICALS LTD
招募中
3 期
Clinical study on Rheumatoid arthritis -AMRACTRI/2022/12/047807Central Council for Research in Ayurvedic Science CCRAS